Eventide Healthcare Innovation Fund II LP
Raised
Pre-open
Investors
—
Min Invest
$1,000,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
AltStreet Analysis
·Generated from EDGAR primary sources
Eventide Healthcare Innovation Fund II LP is a Delaware limited partnership formed as a pooled investment vehicle, filed under Form D by Eventide Asset Management, LLC and its GP affiliate Eventide Healthcare Innovation Fund II GP LLC. The filing shows total amount sold as pre-open/not disclosed, investor count not disclosed, and a stated minimum investment of $1.0M, claimed under Rule 506(c) alongside a 3(c) Investment Company Act exclusion. No parent platform or sibling entities were identified in available records.
This is a private pooled investment fund raising equity under the 506(c)/3(c) exemption pairing common to institutional private funds seeking general solicitation ability while remaining excluded from Investment Company Act registration. A $1.0M minimum investment places it in the upper tier of typical alternative investment offerings, consistent with a fund targeting institutional or high-net-worth investors rather than a broadly distributed vehicle.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
1
latest Oct 28, 2026
Critical / warning
0 / 0
0 watch · 1 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
pre_sale
Latest event New filer · Oct 28, 2026
SEC.govFund family Part of the Eventide Healthcare Innovation Fund family: 2 vehicles across 2 generations · full family and the filing behind each link in the terminal
Investor
- The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
- 1 filing event with values and deltas, latest 2026-10-28, and alerts on the next one
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
N/A Eventide Healthcare Innovation Fund II GP LLC
Promoter · Boston, MA
N/A Eventide Asset Management, LLC
Promoter · Boston, MA
Robin John
Executive Officer · Boston, MA
Sean Mathew
Executive Officer · Boston, MA
Finny Kuruvilla
Executive Officer · Boston, MA
I-hung Shih
Executive Officer · Boston, MA
Peter Luiso
Executive Officer · Boston, MA
Jennifer Reiche
Executive Officer · Boston, MA
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
Jon Michael SchnackenbergCRD 5320862 on BrokerCheck
Associated broker-dealer: Foreside Fund Services, LLC (CRD 46106) · Portland, ME · Soliciting in all states
Matthew M McEathronCRD 7433450 on BrokerCheck
Associated broker-dealer: Foreside Fund Services, LLC (CRD 46106) · Portland, ME · Soliciting in all states
Stuart L SlackCRD 2920127 on BrokerCheck
Associated broker-dealer: Foreside Fund Services, LLC (CRD 46106) · Portland, ME · Soliciting in all states
Spencer MartinCRD 6809671 on BrokerCheck
Associated broker-dealer: Foreside Fund Services, LLC (CRD 46106) · Portland, ME · Soliciting in all states
Mark WamboltCRD 4966496 on BrokerCheck
Associated broker-dealer: Foreside Fund Services, LLC (CRD 46106) · Portland, ME · Soliciting in all states
Questions About Eventide Healthcare Innovation Fund II LP
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Eventide Healthcare Innovation Fund II LP?
Eventide Healthcare Innovation Fund II LP is a Delaware limited partnership organized in 2026 that filed a Form D with the SEC on October 28, 2026 as a private equity fund. The filing claims Rule 506(c), Section 3(c), Section 3(c)(7) for an offering of equity and pooled investment fund interests.
Is Eventide Healthcare Innovation Fund II LP legit?
AltStreet does not rate legitimacy; it reports the public record. Eventide Healthcare Innovation Fund II LP filed a Form D with the SEC on October 28, 2026 claiming Rule 506(c), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. No sales had been reported as of that notice. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Eventide Healthcare Innovation Fund II LP registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Eventide Healthcare Innovation Fund II LP claimed Rule 506(c), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Eventide Healthcare Innovation Fund II LP raised?
Eventide Healthcare Innovation Fund II LP reported that the first sale had not yet occurred as of the Form D filed October 28, 2026, so no amount sold or investor count is on file. The total offering amount is listed as indefinite.
Who can invest in Eventide Healthcare Innovation Fund II LP?
The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $1,000,000.
What is the minimum investment in Eventide Healthcare Innovation Fund II LP?
The Form D lists $1,000,000 as the minimum investment accepted from any outside investor as of October 28, 2026. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling Eventide Healthcare Innovation Fund II LP and how are they paid?
The Form D names Jon Michael Schnackenberg (CRD 5320862), associated with Foreside Fund Services, LLC; Matthew M McEathron (CRD 7433450), associated with Foreside Fund Services, LLC; Stuart L Slack (CRD 2920127), associated with Foreside Fund Services, LLC; Spencer Martin (CRD 6809671), associated with Foreside Fund Services, LLC and 1 other as recipients of sales compensation soliciting in all states. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind Eventide Healthcare Innovation Fund II LP?
The Form D lists 8 related persons: Eventide Healthcare Innovation Fund II GP LLC, promoter (General Partner of the Issuer (the "General Partner")); Eventide Asset Management, LLC, promoter (Manager of the Issuer (the "Manager")); Robin John, executive officer (Chief Executive Officer of the Manager); Sean Mathew, executive officer (Chief Financial Officer of the Manager); Finny Kuruvilla, executive officer (Co-CIO and Managing Director of the Manager); I-hung Shih, executive officer (Managing Director of the Manager); Peter Luiso, executive officer (General Counsel of the Manager); Jennifer Reiche, executive officer (Chief Compliance Officer of the Manager). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Eventide Healthcare Innovation Fund II LP located?
The issuer's address on its SEC filings is One International Place, Suite 4210, Boston, MA 02110. Its phone number of record is 877.771.3836. It is organized under the laws of Delaware.
How long is the Eventide Healthcare Innovation Fund II LP offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
How large is Eventide Healthcare Innovation Fund II LP?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.